Výsledky vyhledávání - Amir Mortazavi
- Zobrazuji výsledky 1 - 20 z 28
- Přejít na další stránku
-
1
-
2
-
3
-
4
Inhibition of bladder cancer by broccoli isothiocyanates sulforaphane and erucin: Characterization, metabolism, and interconversion Autor Besma Abbaoui, Kenneth M. Riedl, Robin A. Ralston, Jennifer M. Thomas‐Ahner, Steven J. Schwartz, Steven K. Clinton, Amir Mortazavi
Vydáno 2012Artigo -
5
-
6
Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches Autor Adam Khorasanchi, Feng Hong, Yuanquan Yang, Eric A. Singer, Peng Wang, Mingjia Li, Linghua Zheng, Paul Monk, Amir Mortazavi, Lingbin Meng
Vydáno 2025Revisão -
7
The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer Autor Besma Abbaoui, Kelly H. Telu, Christopher R. Lucas, Jennifer M. Thomas‐Ahner, Steven J. Schwartz, Steven K. Clinton, Michael A. Freitas, Amir Mortazavi
Vydáno 2017Artigo -
8
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therap... Autor Dixita M. Patel, Ruba Mateen, Noor Qaddour, Alessandra Carrillo, Claire F. Verschraegen, Yuanquan Yang, Zihai Li, Debasish Sundi, Amir Mortazavi, Katharine A. Collier
Vydáno 2024Revisão -
9
Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters Autor Huyen Nguyen, Guang Jia, Zarine K. Shah, Kamal S. Pohar, Amir Mortazavi, Debra L. Zynger, Lai Wei, Xiangyu Yang, Daniel J. Clark, Michael V. Knopp
Vydáno 2014Artigo -
10
Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors Autor Tanios Bekaii‐Saab, Robert Wesolowski, Daniel H. Ahn, Christina Wu, Amir Mortazavi, Maryam B. Lustberg, Bhuvaneswari Ramaswamy, Jeffrey M. Fowler, Lai Wei, Jay Overholser, Pravin T. P. Kaumaya
Vydáno 2019Artigo -
11
Effects of a Group-Mediated Exercise and Dietary Intervention in the Treatment of Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Results From the IDEA-P Trial Autor Brian C. Focht, Alexander R. Lucas, Elizabeth M. Grainger, Christina Simpson, Ciaran M. Fairman, Jennifer M. Thomas‐Ahner, Jackie Buell, J. Paul Monk, Amir Mortazavi, Steven K. Clinton
Vydáno 2018Artigo -
12
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies Autor Bradley A. McGregor, Matthew T. Campbell, Wanling Xie, Subrina Farah, Mehmet Asım Bilen, Andrew Schmidt, Guru Sonpavde, Kerry L. Kilbridge, Atish D. Choudhury, Amir Mortazavi, Amishi Y. Shah, Aradhana M. Venkatesan, Glenn J. Bubley, Arlene O. Siefker‐Radtke, Rana R. McKay, Toni K. Choueiri
Vydáno 2020Artigo -
13
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes Autor Petros Grivas, Amir Mortazavi, Joel Picus, Noah M. Hahn, Matthew I. Milowsky, Lowell L. Hart, Ajjai Alva, Joaquim Bellmunt, Sumanta K. Pal, Richard Bambury, Peter H. O’Donnell, Sumati Gupta, Elizabeth A. Guancial, Guru Sonpavde, Demiana Faltaos, Diane Potvin, James G. Christensen, Richard C. Chao, Jonathan E. Rosenberg
Vydáno 2018Artigo -
14
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma Autor Sumanta K. Pal, Paul Frankel, Amir Mortazavi, Matthew I. Milowsky, Ulka N. Vaishampayan, Mamta Parikh, Yung Lyou, Peng Weng, Rahul Atul Parikh, Benjamin A. Teply, Robert Dreicer, Hamid Emamekhoo, M. Dror Michaelson, Christopher Hoimes, Tian Zhang, Sandy Srinivas, William Y. Kim, Yujie Cui, Edward M. Newman, Primo N. Lara
Vydáno 2021Artigo -
15
A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas Autor Douglas W. Sborov, Alessandro Canella, Erinn M. Hade, Xiaokui Mo, Soun Khountham, Jiang Wang, Wenjun Ni, Ming Poi, Christopher C. Coss, Zhongfa Liu, Mitch A. Phelps, Amir Mortazavi, Leslie A. Andritsos, Robert A. Baiocchi, Beth Christian, Don M. Benson, Joseph M. Flynn, Pierluigi Porcu, John C. Byrd, Flavia Pichiorri, Craig C. Hofmeister
Vydáno 2017Artigo -
16
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer Autor Matthew D. Galsky, Amir Mortazavi, Matthew I. Milowsky, Saby George, Sumati Gupta, Mark T. Fleming, Long H. Dang, Daniel M. Geynisman, Radhika Walling, Robert Alter, Mohamad Kassar, Jue Wang, Shilpa Gupta, Nancy B. Davis, Joel Picus, George Philips, David I. Quinn, G. Kenneth Haines, Noah M. Hahn, Qianqian Zhao, Menggang Yu, Sumanta K. Pal
Vydáno 2020Artigo -
17
Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer Autor Toni K. Choueiri, Robert W. Ross, Susanna Jacobus, Ulka N. Vaishampayan, Evan Y. Yu, David I. Quinn, Noah M. Hahn, Thomas E. Hutson, Guru Sonpavde, Stephanie Morrissey, Geoffrey Buckle, William Y. Kim, Daniel P. Petrylak, Christopher W. Ryan, Mario A. Eisenberger, Amir Mortazavi, Glenn J. Bubley, Mary-Ellen Taplin, Jonathan E. Rosenberg, Philip W. Kantoff
Vydáno 2011Artigo -
18
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance) Autor Jonathan E. Rosenberg, Karla V. Ballman, Susan Halabi, Philip J. Atherton, Amir Mortazavi, Christopher J. Sweeney, Walter M. Stadler, Benjamin A. Teply, Joel Picus, Scott T. Tagawa, Sreedhar Katragadda, Daniel A. Vaena, Jamal Misleh, Christopher Hoimes, Elizabeth R. Plimack, Thomas W. Flaig, Robert Dreicer, Dean F. Bajorin, Olwen Hahn, Eric J. Small, Michael J. Morris
Vydáno 2021Artigo -
19
Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective study Autor Cassandra Duarte, Junxiao Hu, Benoit Beuselinck, Justine Panian, Nicole Weise, Nazlı Dizman, Katharine A. Collier, Nityam Rathi, Haoran Li, Roy Elias, Nieves Martínez Chanzá, Tracy L. Rose, Lauren C. Harshman, Dharmesh Gopalakrishnan, Ulka N. Vaishampayan, Yousef Zakharia, Vivek Narayan, Benedito A. Carneiro, Anthony Mega, Nirmish Singla, Cheryl Meguid, Saby George, James Brugarolas, Neeraj Agarwal, Amir Mortazavi, Sumanta K. Pal, Rana R. McKay, Elaine T. Lam
Vydáno 2023Artigo -
20
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma Autor Laure Hirsch, Nieves Martínez Chanzá, Subrina Farah, Wanling Xie, Ronan Flippot, David A. Braun, Nityam Rathi, Jonathan Thouvenin, Katharine A. Collier, Emmanuel Seront, Guillermo de Velasco, Hannah Dzimitrowicz, Benoit Beuselinck, Wenxin Xu, I. Alex Bowman, Elaine T. Lam, Bashar Abuqayas, Mehmet Asım Bilen, Andreas Varkaris, Yousef Zakharia, Michael R. Harrison, Amir Mortazavi, Philippe Barthélémy, Neeraj Agarwal, Rana R. McKay, Priscilla K. Brastianos, Katherine M. Krajewski, Laurence Albigès, Lauren C. Harshman, Toni K. Choueiri
Vydáno 2021Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Cancer
Oncology
Bladder cancer
Immunotherapy
Renal cell carcinoma
Metastatic Urothelial Carcinoma
Urology
Urothelial carcinoma
Biology
Cancer research
Clinical trial
Biochemistry
Cabozantinib
Chemotherapy
Nivolumab
Adverse effect
Chemistry
Gastroenterology
Ipilimumab
Kidney cancer
Randomized controlled trial
Surgery
Alternative medicine
Breast cancer
Clinical endpoint
Cohort
Cruciferous vegetables
Gemcitabine